CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,900 | $53.13 | $101K | 92,477 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −88 | $54.14 | $5K | 92,389 |
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −600 | 3,070 | ||
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,720 | 61,110 | ||
| 2024-12-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,988 | 15,512 | ||
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +2,594 | $51.00 | $132K | 88,796 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −2,328 | $51.85 | $121K | 86,468 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −266 | $52.73 | $14K | 86,202 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +66,956 | $51.00 | $3.4M | 153,158 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −58,345 | $51.97 | $3.0M | 94,813 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −8,611 | $52.72 | $454K | 86,202 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +2,060 | $51.00 | $105K | 6,636 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −1,783 | $51.85 | $92K | 4,853 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −277 | $52.76 | $15K | 4,576 |
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,594 | 66,956 | ||
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −66,956 | 0 | ||
| 2024-12-02 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,060 | 0 | ||
| 2024-12-02 | ZELDIS JEROME B Director | Option exercise 10b5-1 | +12,000 | $51.00 | $612K | 26,500 |
| 2024-12-02 | ZELDIS JEROME B Director | Sale 10b5-1 | −8,813 | $51.44 | $453K | 17,687 |
| 2024-12-02 | ZELDIS JEROME B Director | Sale 10b5-1 | −3,187 | $52.42 | $167K | 14,500 |
Page 31 of 41 · 804 trades